Clinical Validation of the Comprehensive Complication Index as a Measure of Postoperative Morbidity at a Surgical Department

医学 观察研究 并发症 外科 前瞻性队列研究 多元分析 队列研究 队列 内科学
作者
Roberto de la Plaza Llamas,José Manuel Ramia,Juan M. Bellón,Vladimir Arteaga Peralta,C. García Amador,A. Lopez Marcano,Á. Velasco,Begoña González Sierra,Alba Manuel Vázquez
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:268 (5): 838-844 被引量:70
标识
DOI:10.1097/sla.0000000000002839
摘要

Objective: Using clinical outcomes, to validate the comprehensive complication index (CCI) as a measure of postoperative morbidity in all patients undergoing surgery at a general surgery department. Background: The Clavien-Dindo classification (CDC) is the most widely used system to assess postoperative morbidity. The CCI is a numerical scale based on the CDC. Once validated, it could be used universally to establish and compare the real postoperative complications of each surgical procedure. Methods: Observational prospective cohort study. All patients who underwent surgery during the 1-year study period were included. All the complications graded with the CDC and related to the initial admission, or until discharge if the patient was readmitted within 90 days of surgery, were included. Surgical procedures were classified according to the operative severity score (OSS) as minor, moderate, major, or major+. The clinical validation of the CCI was performed by assessing its correlation with 4 different clinical outcomes. Results: A total of 1850 patients were included: 513 (27.7%) presented complications and 101 (5.46%) were readmitted. In the multivariate analysis, the CCI and CDC were associated with postoperative stay, prolongation of postoperative stay, readmission, and disability in all OSS groups ( P < 0.001). The CCI was superior to the CDC in all models except for prolongation of stay for OSS moderate and major+. Conclusions: The CCI can be applied in all the procedures carried out at general surgery departments. It is able to determine the morbidity and allows the comparison of the outcomes at different services.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
如风完成签到,获得积分10
刚刚
depurge完成签到,获得积分10
刚刚
顾矜应助icypz628采纳,获得10
刚刚
Maestro_S完成签到,获得积分0
刚刚
刚刚
Stella举报8899求助涉嫌违规
1秒前
rpFengMing完成签到,获得积分10
1秒前
修炼哥完成签到,获得积分10
1秒前
高皮皮完成签到,获得积分10
1秒前
不想看文献完成签到,获得积分10
1秒前
1秒前
Eeee完成签到,获得积分10
1秒前
2秒前
xiaoniu完成签到,获得积分10
2秒前
机智的大狸子完成签到,获得积分10
2秒前
lifeng完成签到 ,获得积分10
2秒前
Alora完成签到,获得积分10
2秒前
Owen应助迷路的文涛采纳,获得10
2秒前
DragonAca发布了新的文献求助10
3秒前
蓝色斑马完成签到,获得积分10
3秒前
LewisAcid应助ADChem_JH采纳,获得200
3秒前
LLLLLLLL完成签到,获得积分10
3秒前
机灵一兰发布了新的文献求助10
4秒前
安可瓶子发布了新的文献求助10
4秒前
蓝莓橘子酱应助yq采纳,获得10
4秒前
852应助与非采纳,获得10
4秒前
winwin完成签到,获得积分10
4秒前
沙特发布了新的文献求助10
4秒前
LXJY完成签到,获得积分10
4秒前
只因完成签到,获得积分10
5秒前
5秒前
落水者发布了新的文献求助10
5秒前
yybo完成签到,获得积分10
5秒前
我是老大应助高生金英采纳,获得10
5秒前
有魅力的怜南完成签到,获得积分10
5秒前
青木蓝完成签到,获得积分10
6秒前
tennisgirl完成签到 ,获得积分10
6秒前
眯眯眼的以蕊完成签到,获得积分10
8秒前
8秒前
shuo发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6043420
求助须知:如何正确求助?哪些是违规求助? 7805940
关于积分的说明 16239848
捐赠科研通 5189087
什么是DOI,文献DOI怎么找? 2776820
邀请新用户注册赠送积分活动 1759853
关于科研通互助平台的介绍 1643355